New export legislation allows Danish manufacturers to export.
The Danish pilot programme with medical cannabis.
New market for products with high CBD content.
1 January 2018, the new pilot program for medical cannabis entered in Denmark. The Danish pilot programme with medical cannabis proceeds over the next 4 years until the end of 2021. The pilot program will be evaluated on a continuous basis and at the end of the period new initiatives will be discussed for future prospects for medical cannabis in Denmark.
A total domestic market close to potential 5.7M people, and a total healthcare expenditure (2017) of over €22.6B.
Medical cannabis is typically prescribed to the following patient groups in Denmark:
Over 700.000 people in Denmark are affected by arthritis - equivalent to every eighth Dane.
Over 200.000 living Danes have at some point been diagnosed with cancer - one third of all Danes get cancer.
Over 50.000 people in Denmark have epilepsy - a patient group that grows by over 5.000 people progressively every year.
Copyright © DANCANN 2018 All rights reserved